Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo.
about
Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy.Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factorsGATA-dependent recruitment of MEF2 proteins to target promotersTranscription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain geneMutational analysis of the DNA binding, dimerization, and transcriptional activation domains of MEF2CAngiotensin II type1a receptor gene expression in the heart: AP-1 and GATA-4 participate in the response to pressure overloadDistinct gene expression patterns in skeletal and cardiac muscle are dependent on common regulatory sequences in the MLC1/3 locusMEF2B is a potent transactivator expressed in early myogenic lineagesControl of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2CMEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in miceLoss of Frataxin induces iron toxicity, sphingolipid synthesis, and Pdk1/Mef2 activation, leading to neurodegeneration.Myocardial molecular biology: an introduction.Re-employment of developmental transcription factors in adult heart diseaseTranscription of the human beta enolase gene (ENO-3) is regulated by an intronic muscle-specific enhancer that binds myocyte-specific enhancer factor 2 proteins and ubiquitous G-rich-box binding factors.Quantitative discrimination of MEF2 sites.A Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.An M-CAT binding factor and an RSRF-related A-rich binding factor positively regulate expression of the alpha-cardiac myosin heavy-chain gene in vivo.EFIA/YB-1 is a component of cardiac HF-1A binding activity and positively regulates transcription of the myosin light-chain 2v geneKruppel-like Factors (KLFs) in muscle biologyFactors controlling cardiac myosin-isoform shift during hypertrophy and heart failureSex modifies exercise and cardiac adaptation in miceMef2c is an essential regulatory element required for unique expression of the cardiac-specific CARK gene.Myocyte-specific enhancer factor 2C: a novel target gene of miR-214-3p in suppressing angiotensin II-induced cardiomyocyte hypertrophyThe Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression.Transcription factors in heart: promising therapeutic targets in cardiac hypertrophy.Myocardial plasticity: cardiac development, regeneration and disease.A positive GATA element and a negative vitamin D receptor-like element control atrial chamber-specific expression of a slow myosin heavy-chain gene during cardiac morphogenesis.Physical interaction between TBX5 and MEF2C is required for early heart development.Serum induction of MEF2/RSRF expression in vascular myocytes is mediated at the level of translation.Myocyte-specific enhancer factor 2 and thyroid hormone receptor associate and synergistically activate the alpha-cardiac myosin heavy-chain gene.Ca2+/Calmodulin-Dependent Protein Kinase II and Androgen Signaling Pathways Modulate MEF2 Activity in Testosterone-Induced Cardiac Myocyte Hypertrophy.Comparative analysis reveals distinct and overlapping functions of Mef2c and Mef2d during cardiogenesis in Xenopus laevis.Effects of new polymorphisms in the bovine myocyte enhancer factor 2D (MEF2D) gene on the expression rates of the longissimus dorsi muscle.Promoter variant-dependent mRNA expression of the MEF2A in longissimus dorsi muscle in cattle.A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac alpha-myosin heavy chain gene.Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice.Left ventricular hypertrophy in experimental chronic kidney disease is associated with reduced expression of cardiac Kruppel-like factor 15.
P2860
Q24302601-E346DA23-C90A-4797-81E6-544D32AC3219Q24594377-A6B69BB5-B54D-442C-B254-DFCE5B9FA903Q24599616-FF7FA179-F12A-434B-8FD6-D05E89E120F3Q24611410-B1BF3F09-1FBD-41A9-911F-00D0D98D8C04Q24649105-5F9ABD18-E6D9-4A39-BD97-C4E161E8FC6CQ24654964-311E00B0-698A-4FDF-9416-95BE45A29204Q28504737-F7FFB3EE-9A9A-4E35-9179-01284CB2FD48Q28505977-43C5AF1E-4FA9-4316-9161-8F06791D2908Q28589290-4C0A75B4-B5CD-4A9E-A6D3-E6B01A4F1BD4Q33521236-57491F1F-D37C-4B77-AE59-F57022C78B9DQ34531992-309CA655-9196-40B1-9E23-4DF03D97BBA0Q34532862-DFEDF32B-BAD1-42F7-BAF2-E1C9B126F577Q35757916-5CED21AC-37A5-4B1E-A779-9426882B9A3BQ36555690-9A89771C-A594-4D63-BF98-88A373CC8946Q36556982-DD113CB0-3BB4-4CA4-B092-7F39DEA843B8Q36647589-BBB82409-14F7-4134-BEDF-DD7E15957982Q36662312-EABC956C-8790-46D3-BEE1-8C48B7A8DD59Q36704684-8323C8ED-2564-4DA4-839D-14AA62B5EE3BQ36832584-98108A9B-7645-4769-A468-3FD272891AF3Q36919409-7AF61E27-DC51-428C-A92E-34B21B6154CAQ37086781-5D05E45E-3083-49A4-807A-5C4A8C1641DCQ37296387-CA3FDE3F-9706-4118-BDF8-218B41B91223Q37380034-C3230973-7A27-4729-BBFB-235F0A762C51Q37515701-B01C09CE-17E1-46F8-81FA-626686060105Q38023555-A757433B-1965-4ACE-9606-7742C005B7FBQ38920772-3F23A03B-8E54-4D54-A196-FE2AB5B09FFEQ39576269-73A965E2-B0FD-4781-9404-23928288280CQ39885692-4E42099D-B299-47FB-991C-B1B6EC58C022Q40016503-CB92B6DE-48DF-4056-9D78-7F6D7BFEA40CQ40022150-CB4C46C5-521B-4034-9B9A-2B0633C1A768Q41684493-FE935B8E-C518-4DF4-83AD-EF2BAEC0995CQ41896719-CDD1F4B0-BFE7-4EFB-B055-ECCBF9787204Q41915667-16136A01-DDBD-4CC1-89F8-BB0A0F664EFCQ41980760-E31123EF-6673-448A-99B1-A3A0F2299561Q42986977-9FF548F4-188A-4087-8F54-D072D65414C5Q45404113-6EA78C8E-88E1-4069-A7DE-1AA6F3AB956FQ55467665-12844631-EAFC-410E-8639-CF8801AC970D
P2860
Myocyte-specific enhancer-binding factor (MEF-2) regulates alpha-cardiac myosin heavy chain gene expression in vitro and in vivo.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Myocyte-specific enhancer-bind ...... pression in vitro and in vivo.
@en
type
label
Myocyte-specific enhancer-bind ...... pression in vitro and in vivo.
@en
prefLabel
Myocyte-specific enhancer-bind ...... pression in vitro and in vivo.
@en
P1476
Myocyte-specific enhancer-bind ...... xpression in vitro and in vivo
@en
P2093
Markham BE
Molkentin JD
P304
19512-19520
P407
P577
1993-09-01T00:00:00Z